[96a5a0]: / output / chiaCancer / identified / NCT00404495_identified.json

Download this file

185 lines (185 with data), 7.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
{
"info": {
"nct_id": "NCT00404495",
"official_title": "Phase 2 Single-Arm, Open Label Study Of Irinotecan In Combination With Temozolomide In Children With Recurrent Or Refractory Medulloblastoma And In Children With Newly Diagnosed High-Grade Glioma.",
"inclusion_criteria": "* Cohort 1: Recurrent or refractory medulloblastoma in which current standard treatment approaches have failed; biopsy is not required for recurrent disease.\n* Cohort 2: Newly-diagnosed high-grade glioma (World Health Organization [WHO] grade 3 or 4)\n* Life expectancy ≥ 3 months\nHealthy volunteers allowed\nMust have minimum age of 6 Months\nMust have maximum age of 18 Years",
"exclusion_criteria": "* Diagnosis of brainstem glioma\n* Concurrent administration of any other anti-tumor therapy\n* Pre-existing uncontrolled diarrhea",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Cohort 1: Recurrent or refractory medulloblastoma in which current standard treatment approaches have failed; biopsy is not required for recurrent disease.",
"criterions": [
{
"exact_snippets": [
"Recurrent or refractory medulloblastoma"
],
"criterion": "medulloblastoma",
"requirement_type": "status",
"expected_value": [
"recurrent",
"refractory"
]
},
{
"exact_snippets": [
"current standard treatment approaches have failed"
],
"criterion": "standard treatment",
"requirement_type": "outcome",
"expected_value": "failed"
},
{
"exact_snippets": [
"biopsy is not required for recurrent disease"
],
"criterion": "biopsy",
"requirement_type": "requirement",
"expected_value": false
}
]
},
{
"line": "* Cohort 2: Newly-diagnosed high-grade glioma (World Health Organization [WHO] grade 3 or 4)",
"criterions": [
{
"exact_snippets": [
"Newly-diagnosed"
],
"criterion": "diagnosis status",
"requirement_type": "recency",
"expected_value": "newly-diagnosed"
},
{
"exact_snippets": [
"high-grade glioma"
],
"criterion": "glioma",
"requirement_type": "grade",
"expected_value": "high-grade"
},
{
"exact_snippets": [
"World Health Organization [WHO] grade 3 or 4"
],
"criterion": "glioma",
"requirement_type": "WHO grade",
"expected_value": [
"3",
"4"
]
}
]
},
{
"line": "* Life expectancy ≥ 3 months",
"criterions": [
{
"exact_snippets": [
"Life expectancy ≥ 3 months"
],
"criterion": "life expectancy",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3
}
]
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 6 Months",
"criterions": [
{
"exact_snippets": [
"minimum age of 6 Months"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 0.5
}
}
]
},
{
"line": "Must have maximum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"maximum age of 18 Years"
],
"criterion": "age",
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 18
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Diagnosis of brainstem glioma",
"criterions": [
{
"exact_snippets": [
"Diagnosis of brainstem glioma"
],
"criterion": "brainstem glioma",
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"line": "* Concurrent administration of any other anti-tumor therapy",
"criterions": [
{
"exact_snippets": [
"Concurrent administration of any other anti-tumor therapy"
],
"criterion": "anti-tumor therapy",
"requirement_type": "concurrent administration",
"expected_value": true
}
]
},
{
"line": "* Pre-existing uncontrolled diarrhea",
"criterions": [
{
"exact_snippets": [
"Pre-existing uncontrolled diarrhea"
],
"criterion": "diarrhea",
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}